Clinical Trial Update: Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating mesenchymal stem cells for treatment of poor graft function after allogeneic hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: ShiCang Yu | Conditions: MSC | Phase 4 | Status: NOT_YET_RECRUITING